# The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study

> **NCT05462548** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 20 (estimated)

## Conditions studied

- Thalassemia Major
- Transfusion-dependent Anemia

## Interventions

- **DRUG:** Luspatercept Injectable Product

## Key facts

- **NCT ID:** NCT05462548
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-04-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05462548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05462548, "The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05462548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*